DURECT is a biopharmaceutical company focused on the development of medicines that provide meaningful advances in patient health and wellbeing. An endogenous, orally bioavailable small molecule in development for chronic liver disease and acute organ injury. DURECT is focusing its efforts on therapeutic areas with significant unmet need, including diseases with no approved treatments like alcoholic hepatitis (AH) and non-alcoh...
DURECT is a biopharmaceutical company focused on the development of medicines that provide meaningful advances in patient health and wellbeing. An endogenous, orally bioavailable small molecule in development for chronic liver disease and acute organ injury. DURECT is focusing its efforts on therapeutic areas with significant unmet need, including diseases with no approved treatments like alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.